Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Advanced Solid Tumor 6Carcinoma, Hepatocellular 4Carcinoma, Non-Small-Cell Lung 3Stomach Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Advanced Solid Tumors 2Advanced Lung Cancer 2Urinary Bladder Neoplasms 1Treatment-naive Advanced Non-small Cell Lung Cancer 1Sarcoma 1Recurrence 1Mouth Neoplasms 1Melanoma 1Lymphoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Rectal Cancer 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1High-Risk Resectable NSCLC 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Brain Neoplasms 1Anus Neoplasms 1Anal Canal Carcinoma 1Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy 1

Interventions

aldesleukin 26Sunitinib 25Interferon-alpha 21Everolimus 18Sorafenib 16Cyclophosphamide 16Filgrastim 13Bevacizumab 13Nivolumab 11Gemcitabine 11Interleukin-2 10Axitinib 10fludarabine phosphate 9Gene Expression Profiling 9temsirolimus 8Peripheral Blood Stem Cell Transplantation 8Doxorubicin 8pembrolizumab 7Radiotherapy 6Radiosurgery 6Polymerase Chain Reaction 6Ipilimumab 6Carboplatin 6sargramostim 5Ifosfamide 5Fluorouracil 5Erlotinib Hydrochloride 5Capecitabine 5Bortezomib 5atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Kidney Neoplasms × toripalimab × Clear all
NCT04374877 2025-11-10

Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Completed
145 enrolled
GastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡